Andrew W Hahn
Overview
Explore the profile of Andrew W Hahn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
880
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma J, Delaney J, Ruderman S, Nance R, Hahn A, Drumright L, et al.
AIDS Behav
. 2024 Dec;
29(2):480-481.
PMID: 39625560
No abstract available.
2.
Hahn A, Aparicio A, Jadvar H, Poon D
Prostate Cancer Prostatic Dis
. 2024 Nov;
PMID: 39558122
No abstract available.
3.
Koutroumpakis E, Venkatesh N, Aparicio A, Song J, Panaretakis T, Deswal A, et al.
Oncologist
. 2024 Nov;
PMID: 39557398
Background: Convergent data suggest that advanced prostate cancer and coronary heart disease (CHD) share biological vulnerabilities that may be linked to adiposity. Here we explore whether leptin, as a marker...
4.
Koutroumpakis E, Patel R, Khadke S, Bedrosian A, Kumar A, Kong Y, et al.
Cardiovasc Drugs Ther
. 2024 Nov;
PMID: 39527237
Purpose: Studies have reported associations between prostate cancer, type II diabetes mellitus (T2DM), and cardiovascular disease in the context of treatment with hormone therapy (HT). This study aimed to assess...
5.
Gregg J, Newcomb L, Wu R, Dennison J, Davis J, Pettaway C, et al.
Biomark Res
. 2024 Nov;
12(1):134.
PMID: 39522029
Background: We previously reported that increases in circulating sphingolipids are associated with elevated risk of biopsy Gleason grade group (GG) upgrading in men on Active Surveillance (AS) for prostate cancer....
6.
Ma J, Delaney J, Ruderman S, Nance R, Hahn A, Drumright L, et al.
AIDS Behav
. 2024 Oct;
29(2):468-479.
PMID: 39465466
Substance use is associated with decreased antiretroviral therapy (ART) adherence among people with HIV (PWH). Adherence plays a significant role in mediating the negative effects of substance use on HIV...
7.
Ruderman S, Hunt P, Beck-Engeser G, Ambayec G, Willig A, Saag M, et al.
AIDS
. 2024 Oct;
39(2):153-161.
PMID: 39453872
Background: Frailty occurs at higher rates and younger ages among people with HIV (PWH) compared with the general population and is often attributed to chronic inflammation and subsequent immune exhaustion....
8.
Venkatesh N, Tidwell R, Yu Y, Aparicio A, Zurita A, Subudhi S, et al.
Endocr Relat Cancer
. 2024 Sep;
31(12).
PMID: 39324992
Hormone therapy (HT) to treat prostate cancer is reported to cause adverse changes in body composition. Clinically, interpatient body composition changes are heterogeneous, but the biological and clinical determinants of...
9.
Wang E, Rupe E, Mukhida S, Johns A, Campbell M, Shah A, et al.
Eur Urol Focus
. 2024 Sep;
PMID: 39307587
Background And Objective: Belzutifan, a hypoxia-inducible factor 2 alpha inhibitor, was approved initially for patients with von Hippel-Lindau disease and more recently for sporadic, metastatic clear cell renal cell carcinoma...
10.
Koutroumpakis E, Patel R, Khadke S, Bedrosian A, Kumar A, Kong Y, et al.
Res Sq
. 2024 Aug;
PMID: 39108488
Background: Studies have reported associations between prostate cancer, type II diabetes mellitus (T2DM) and cardiovascular disease in the context of treatment with hormone therapy (HT). This study aimed to assess...